Non-invasive prenatal diagnosis of β-thalassemia by detection of the cell-free fetal DNA in maternal circulation: a systematic review and meta-analysis

Ann Hematol. 2016 Aug;95(8):1341-50. doi: 10.1007/s00277-016-2620-3. Epub 2016 Mar 12.

Abstract

The discovery of fetal DNA (f-DNA) opens the possibility of early non-invasive procedure for detection of paternally inherited mutation of beta-thalassemia. Since 2002, some studies have examined the sensitivity and specificity of this method for detection of paternally inherited mutation of thalassemia in pregnant women at risk of having affected babies. We conducted a systematic review of published articles that evaluated using this method for early detection of paternally inherited mutation in maternal plasma. A sensitive search of multiple databases was done in which nine studies met our inclusion criteria. The sensitivity and specificity was 99 and 99 %, respectively. The current study found that detection of paternally inherited mutation of thalassemia using analysis of cell-free fetal DNA is highly accurate. This method could replace conventional and invasive methods.

Keywords: Detection of paternally inherited mutation; Maternal plasma; Non-invasive prenatal diagnosis; Thalassemia; f-DNA.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Cell-Free System
  • DNA / blood*
  • DNA / genetics
  • Female
  • Fetus / metabolism
  • Humans
  • Pregnancy
  • Prenatal Diagnosis / methods*
  • Reproducibility of Results
  • Sensitivity and Specificity
  • beta-Thalassemia / blood*
  • beta-Thalassemia / diagnosis*
  • beta-Thalassemia / genetics

Substances

  • DNA